A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Condition: Acromegaly Intervention: Drug: CAM2029 (octreotide subcutaneous depot) Sponsor: Camurus AB Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 14, 2019 Category: Research Source Type: clinical trials
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Condition: Acromegaly Interventions: Drug: CAM2029 (octreotide subcutaneous depot); Drug: Matching placebo Sponsor: Camurus AB Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 2, 2019 Category: Research Source Type: clinical trials